TAZ in Human Cancer Article Swipe

PDF

Olaf Klingbeil , Damianos Skopelitis , Claudia Tonelli , Toyoki Yoshimoto , Aktan Alpsoy , Maria C. Panepinto , Francesca Minicozzi , Joseph R. Merrill , Amanda M. Cafiero , Disha Aggarwal , Suzanne Russo , Taehoon Ha , Osama E. Demerdash , Tse-Luen Wee , David L. Spector , Scott K. Lyons , David A. Tuveson , Paolo Cifani , Christopher R. Vakoc ·

YOU? · · 2024 · Open Access · · DOI: https://doi.org/10.1158/2159-8290.27938750

A, Western blot analysis of YAP localization following doxycycline (Dox) induced empty vector control, MKIWT or MKIMUT expression for 24h in YAPC cells. Nuclear (Nuc) and cytosolic (Cyto) fractionation are indicated. (Data shown are an extension of Fig. 6E). B, Western blot analysis in YAPC cells. C, Gene set enrichment analysis (GSEA) of RNA-seq data from MKIWT compared to MKIMUT expressing MDA-MB231 cells. Normalized enrichment score (NES) and P value are shown. D, E, Western blot analysis of MARK2,3 specific substrates phosphorylation following MKI/MARK2,3 analog sensitive mutant co-overexpression in HEK-293T cells. F, Competition-based fitness assays in dCas9VPR-expressing YAPC cells after lentiviral expression of sgRNA targeting promoters of indicated genes and expression of MKI (expression of MKI was linked to GFP). Data are shown as mean ± SD of normalized %GFP+ (to day 3 after infection). n=3-9. G, qPCR of MARK2 mRNA following CRISPR activation in dCas9VPR expressing YAPC cells. Housekeeping gene and Ctrl normalized expression is shown. n=3. P value was calculated using a two-tailed parametric t-test with Welch’s correction. H, Tumor volume quantification using NIS-SPECT imaging at indicated time points. n=10 per group. P value was calculated using a two-tailed parametric t-test with Welch’s correction. I, Growth kinetics of subcutaneous YAPC xenografts implanted in immunodeficient mice. Expression of MKIWT from doxycycline (Dox)-inducible lentiviral construct was induced on day 10 post-injection of the cells. Data are shown as mean ± SD. n=5 per group. P values are calculated using a mixed effects model (considering the interaction of experimental groups over time) compared to Ctrl group (-Dox) and corrected with Bonferroni-Holm (BH). J, Tumor image at the end-point of the xenograft experiments shown in I.

Related Topics

Concepts

Kinase Cancer research Cancer Psychology Medicine Cell biology Biology Internal medicine

Metadata

Type: preprint
Language: en
Landing Page: https://doi.org/10.1158/2159-8290.27938750
PDF: https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S10_from_MARK2_MARK3_Kinases_Are_Catalytic_Codependencies_of_YAP_TAZ_in_Human_Cancer/27938750/1/files/50907206.pdf
OA Status: gold
Related Works: 10
OpenAlex ID: https://openalex.org/W4404933728

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4404933728

Canonical identifier for this work in OpenAlex
DOI: https://doi.org/10.1158/2159-8290.27938750

Digital Object Identifier
Title: Supplementary Figure S10 from MARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer

Work title
Type: preprint

OpenAlex work type
Language: en

Primary language
Publication year: 2024

Year of publication
Publication date: 2024-12-02

Full publication date if available
Authors: Olaf Klingbeil, Damianos Skopelitis, Claudia Tonelli, Toyoki Yoshimoto, Aktan Alpsoy, Maria C. Panepinto, Francesca Minicozzi, Joseph R. Merrill, Amanda M. Cafiero, Disha Aggarwal, Suzanne Russo, Taehoon Ha, Osama E. Demerdash, Tse-Luen Wee, David L. Spector, Scott K. Lyons, David A. Tuveson, Paolo Cifani, Christopher R. Vakoc

List of authors in order
Landing page: https://doi.org/10.1158/2159-8290.27938750

Publisher landing page
PDF URL: https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S10_from_MARK2_MARK3_Kinases_Are_Catalytic_Codependencies_of_YAP_TAZ_in_Human_Cancer/27938750/1/files/50907206.pdf

Direct link to full text PDF
Open access: Yes

Whether a free full text is available
OA status: gold

Open access status per OpenAlex
OA URL: https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S10_from_MARK2_MARK3_Kinases_Are_Catalytic_Codependencies_of_YAP_TAZ_in_Human_Cancer/27938750/1/files/50907206.pdf

Direct OA link when available
Concepts: Kinase, Cancer research, Cancer, Psychology, Medicine, Cell biology, Biology, Internal medicine

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex
Related works (count): 10

Other works algorithmically related by OpenAlex

Full payload

id	https://openalex.org/W4404933728
doi	https://doi.org/10.1158/2159-8290.27938750
ids.doi	https://doi.org/10.1158/2159-8290.27938750
ids.openalex	https://openalex.org/W4404933728
fwci
type	preprint
title	Supplementary Figure S10 from MARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T12065
topics[0].field.id	https://openalex.org/fields/13
topics[0].field.display_name	Biochemistry, Genetics and Molecular Biology
topics[0].score	0.9843999743461609
topics[0].domain.id	https://openalex.org/domains/1
topics[0].domain.display_name	Life Sciences
topics[0].subfield.id	https://openalex.org/subfields/1307
topics[0].subfield.display_name	Cell Biology
topics[0].display_name	Hippo pathway signaling and YAP/TAZ
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C184235292
concepts[0].level	2
concepts[0].score	0.6936942934989929
concepts[0].wikidata	https://www.wikidata.org/wiki/Q421851
concepts[0].display_name	Kinase
concepts[1].id	https://openalex.org/C502942594
concepts[1].level	1
concepts[1].score	0.4214581251144409
concepts[1].wikidata	https://www.wikidata.org/wiki/Q3421914
concepts[1].display_name	Cancer research
concepts[2].id	https://openalex.org/C121608353
concepts[2].level	2
concepts[2].score	0.42121025919914246
concepts[2].wikidata	https://www.wikidata.org/wiki/Q12078
concepts[2].display_name	Cancer
concepts[3].id	https://openalex.org/C15744967
concepts[3].level	0
concepts[3].score	0.3554154336452484
concepts[3].wikidata	https://www.wikidata.org/wiki/Q9418
concepts[3].display_name	Psychology
concepts[4].id	https://openalex.org/C71924100
concepts[4].level	0
concepts[4].score	0.28168803453445435
concepts[4].wikidata	https://www.wikidata.org/wiki/Q11190
concepts[4].display_name	Medicine
concepts[5].id	https://openalex.org/C95444343
concepts[5].level	1
concepts[5].score	0.21973881125450134
concepts[5].wikidata	https://www.wikidata.org/wiki/Q7141
concepts[5].display_name	Cell biology
concepts[6].id	https://openalex.org/C86803240
concepts[6].level	0
concepts[6].score	0.21368372440338135
concepts[6].wikidata	https://www.wikidata.org/wiki/Q420
concepts[6].display_name	Biology
concepts[7].id	https://openalex.org/C126322002
concepts[7].level	1
concepts[7].score	0.2119109332561493
concepts[7].wikidata	https://www.wikidata.org/wiki/Q11180
concepts[7].display_name	Internal medicine
keywords[0].id	https://openalex.org/keywords/kinase
keywords[0].score	0.6936942934989929
keywords[0].display_name	Kinase
keywords[1].id	https://openalex.org/keywords/cancer-research
keywords[1].score	0.4214581251144409
keywords[1].display_name	Cancer research
keywords[2].id	https://openalex.org/keywords/cancer
keywords[2].score	0.42121025919914246
keywords[2].display_name	Cancer
keywords[3].id	https://openalex.org/keywords/psychology
keywords[3].score	0.3554154336452484
keywords[3].display_name	Psychology
keywords[4].id	https://openalex.org/keywords/medicine
keywords[4].score	0.28168803453445435
keywords[4].display_name	Medicine
keywords[5].id	https://openalex.org/keywords/cell-biology
keywords[5].score	0.21973881125450134
keywords[5].display_name	Cell biology
keywords[6].id	https://openalex.org/keywords/biology
keywords[6].score	0.21368372440338135
keywords[6].display_name	Biology
keywords[7].id	https://openalex.org/keywords/internal-medicine
keywords[7].score	0.2119109332561493
keywords[7].display_name	Internal medicine
language	en
locations[0].id	doi:10.1158/2159-8290.27938750
locations[0].is_oa	True
locations[0].source
locations[0].license	cc-by
locations[0].pdf_url	https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S10_from_MARK2_MARK3_Kinases_Are_Catalytic_Codependencies_of_YAP_TAZ_in_Human_Cancer/27938750/1/files/50907206.pdf
locations[0].version	acceptedVersion
locations[0].raw_type	posted-content
locations[0].license_id	https://openalex.org/licenses/cc-by
locations[0].is_accepted	True
locations[0].is_published	False
locations[0].raw_source_name
locations[0].landing_page_url	https://doi.org/10.1158/2159-8290.27938750
locations[1].id	pmh:oai:figshare.com:article/27938750
locations[1].is_oa	True
locations[1].source.id	https://openalex.org/S4306400572
locations[1].source.issn
locations[1].source.type	repository
locations[1].source.is_oa	False
locations[1].source.issn_l
locations[1].source.is_core	False
locations[1].source.is_in_doaj	False
locations[1].source.display_name	OPAL (Open@LaTrobe) (La Trobe University)
locations[1].source.host_organization	https://openalex.org/I196829312
locations[1].source.host_organization_name	La Trobe University
locations[1].source.host_organization_lineage	https://openalex.org/I196829312
locations[1].license	cc-by
locations[1].pdf_url	https://figshare.com/articles/journal_contribution/Supplementary_Figure_S10_from_MARK2_MARK3_Kinases_Are_Catalytic_Codependencies_of_YAP_TAZ_in_Human_Cancer/27938750
locations[1].version	submittedVersion
locations[1].raw_type	Text
locations[1].license_id	https://openalex.org/licenses/cc-by
locations[1].is_accepted	False
locations[1].is_published	False
locations[1].raw_source_name
locations[1].landing_page_url
indexed_in	crossref
authorships[0].author.id	https://openalex.org/A5013495524
authorships[0].author.orcid	https://orcid.org/0000-0001-7248-7506
authorships[0].author.display_name	Olaf Klingbeil
authorships[0].author_position	first
authorships[0].raw_author_name	Olaf Klingbeil
authorships[0].is_corresponding	False
authorships[1].author.id	https://openalex.org/A5040391300
authorships[1].author.orcid	https://orcid.org/0000-0003-4724-5462
authorships[1].author.display_name	Damianos Skopelitis
authorships[1].author_position	middle
authorships[1].raw_author_name	Damianos Skopelitis
authorships[1].is_corresponding	False
authorships[2].author.id	https://openalex.org/A5056456330
authorships[2].author.orcid	https://orcid.org/0000-0002-5626-3403
authorships[2].author.display_name	Claudia Tonelli
authorships[2].author_position	middle
authorships[2].raw_author_name	Claudia Tonelli
authorships[2].is_corresponding	False
authorships[3].author.id	https://openalex.org/A5007358330
authorships[3].author.orcid
authorships[3].author.display_name	Toyoki Yoshimoto
authorships[3].author_position	middle
authorships[3].raw_author_name	Toyoki Yoshimoto
authorships[3].is_corresponding	False
authorships[4].author.id	https://openalex.org/A5064630705
authorships[4].author.orcid	https://orcid.org/0000-0002-8940-8277
authorships[4].author.display_name	Aktan Alpsoy
authorships[4].author_position	middle
authorships[4].raw_author_name	Aktan Alpsoy
authorships[4].is_corresponding	False
authorships[5].author.id	https://openalex.org/A5075479096
authorships[5].author.orcid	https://orcid.org/0000-0001-7040-8181
authorships[5].author.display_name	Maria C. Panepinto
authorships[5].author_position	middle
authorships[5].raw_author_name	Maria C. Panepinto
authorships[5].is_corresponding	False
authorships[6].author.id	https://openalex.org/A5094041128
authorships[6].author.orcid	https://orcid.org/0009-0007-7910-3342
authorships[6].author.display_name	Francesca Minicozzi
authorships[6].author_position	middle
authorships[6].raw_author_name	Francesca Minicozzi
authorships[6].is_corresponding	False
authorships[7].author.id	https://openalex.org/A5045387099
authorships[7].author.orcid	https://orcid.org/0000-0003-3680-1988
authorships[7].author.display_name	Joseph R. Merrill
authorships[7].author_position	middle
authorships[7].raw_author_name	Joseph R. Merrill
authorships[7].is_corresponding	False
authorships[8].author.id	https://openalex.org/A5112237112
authorships[8].author.orcid
authorships[8].author.display_name	Amanda M. Cafiero
authorships[8].author_position	middle
authorships[8].raw_author_name	Amanda M. Cafiero
authorships[8].is_corresponding	False
authorships[9].author.id	https://openalex.org/A5012404571
authorships[9].author.orcid	https://orcid.org/0000-0002-5374-8165
authorships[9].author.display_name	Disha Aggarwal
authorships[9].author_position	middle
authorships[9].raw_author_name	Disha Aggarwal
authorships[9].is_corresponding	False
authorships[10].author.id	https://openalex.org/A5109930131
authorships[10].author.orcid
authorships[10].author.display_name	Suzanne Russo
authorships[10].author_position	middle
authorships[10].raw_author_name	Suzanne Russo
authorships[10].is_corresponding	False
authorships[11].author.id	https://openalex.org/A5041223935
authorships[11].author.orcid	https://orcid.org/0000-0002-4533-1140
authorships[11].author.display_name	Taehoon Ha
authorships[11].author_position	middle
authorships[11].raw_author_name	Taehoon Ha
authorships[11].is_corresponding	False
authorships[12].author.id	https://openalex.org/A5019084793
authorships[12].author.orcid	https://orcid.org/0000-0002-9896-2077
authorships[12].author.display_name	Osama E. Demerdash
authorships[12].author_position	middle
authorships[12].raw_author_name	Osama E. Demerdash
authorships[12].is_corresponding	False
authorships[13].author.id	https://openalex.org/A5087835152
authorships[13].author.orcid	https://orcid.org/0000-0002-4141-3157
authorships[13].author.display_name	Tse-Luen Wee
authorships[13].author_position	middle
authorships[13].raw_author_name	Tse-Luen Wee
authorships[13].is_corresponding	False
authorships[14].author.id	https://openalex.org/A5079751903
authorships[14].author.orcid	https://orcid.org/0000-0003-3614-4965
authorships[14].author.display_name	David L. Spector
authorships[14].author_position	middle
authorships[14].raw_author_name	David L. Spector
authorships[14].is_corresponding	False
authorships[15].author.id	https://openalex.org/A5042520502
authorships[15].author.orcid	https://orcid.org/0000-0003-0139-6054
authorships[15].author.display_name	Scott K. Lyons
authorships[15].author_position	middle
authorships[15].raw_author_name	Scott K. Lyons
authorships[15].is_corresponding	False
authorships[16].author.id	https://openalex.org/A5072185005
authorships[16].author.orcid	https://orcid.org/0000-0002-8017-2712
authorships[16].author.display_name	David A. Tuveson
authorships[16].author_position	middle
authorships[16].raw_author_name	David A. Tuveson
authorships[16].is_corresponding	False
authorships[17].author.id	https://openalex.org/A5065570052
authorships[17].author.orcid	https://orcid.org/0000-0002-4403-1277
authorships[17].author.display_name	Paolo Cifani
authorships[17].author_position	middle
authorships[17].raw_author_name	Paolo Cifani
authorships[17].is_corresponding	False
authorships[18].author.id	https://openalex.org/A5015010943
authorships[18].author.orcid	https://orcid.org/0000-0002-1158-7180
authorships[18].author.display_name	Christopher R. Vakoc
authorships[18].author_position	last
authorships[18].raw_author_name	Christopher R. Vakoc
authorships[18].is_corresponding	False
has_content.pdf	True
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S10_from_MARK2_MARK3_Kinases_Are_Catalytic_Codependencies_of_YAP_TAZ_in_Human_Cancer/27938750/1/files/50907206.pdf
open_access.oa_status	gold
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Supplementary Figure S10 from MARK2/MARK3 Kinases Are Catalytic Codependencies of YAP/TAZ in Human Cancer
has_fulltext	True
is_retracted	False
updated_date	2025-11-06T03:46:38.306776
primary_topic.id	https://openalex.org/T12065
primary_topic.field.id	https://openalex.org/fields/13
primary_topic.field.display_name	Biochemistry, Genetics and Molecular Biology
primary_topic.score	0.9843999743461609
primary_topic.domain.id	https://openalex.org/domains/1
primary_topic.domain.display_name	Life Sciences
primary_topic.subfield.id	https://openalex.org/subfields/1307
primary_topic.subfield.display_name	Cell Biology
primary_topic.display_name	Hippo pathway signaling and YAP/TAZ
related_works	https://openalex.org/W4391375266, https://openalex.org/W2748952813, https://openalex.org/W2931662336, https://openalex.org/W2077865380, https://openalex.org/W3006817050, https://openalex.org/W4401768695, https://openalex.org/W2765597752, https://openalex.org/W2134894512, https://openalex.org/W2083375246, https://openalex.org/W2067108088
cited_by_count	0
locations_count	2
best_oa_location.id	doi:10.1158/2159-8290.27938750
best_oa_location.is_oa	True
best_oa_location.source
best_oa_location.license	cc-by
best_oa_location.pdf_url	https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S10_from_MARK2_MARK3_Kinases_Are_Catalytic_Codependencies_of_YAP_TAZ_in_Human_Cancer/27938750/1/files/50907206.pdf
best_oa_location.version	acceptedVersion
best_oa_location.raw_type	posted-content
best_oa_location.license_id	https://openalex.org/licenses/cc-by
best_oa_location.is_accepted	True
best_oa_location.is_published	False
best_oa_location.raw_source_name
best_oa_location.landing_page_url	https://doi.org/10.1158/2159-8290.27938750
primary_location.id	doi:10.1158/2159-8290.27938750
primary_location.is_oa	True
primary_location.source
primary_location.license	cc-by
primary_location.pdf_url	https://aacr.figshare.com/articles/journal_contribution/Supplementary_Figure_S10_from_MARK2_MARK3_Kinases_Are_Catalytic_Codependencies_of_YAP_TAZ_in_Human_Cancer/27938750/1/files/50907206.pdf
primary_location.version	acceptedVersion
primary_location.raw_type	posted-content
primary_location.license_id	https://openalex.org/licenses/cc-by
primary_location.is_accepted	True
primary_location.is_published	False
primary_location.raw_source_name
primary_location.landing_page_url	https://doi.org/10.1158/2159-8290.27938750
publication_date	2024-12-02
publication_year	2024
referenced_works_count	0
abstract_inverted_index.3	132
abstract_inverted_index.P	68, 158, 184, 234
abstract_inverted_index.a	163, 189, 239
abstract_inverted_index.10	219
abstract_inverted_index.B,	39
abstract_inverted_index.C,	46
abstract_inverted_index.D,	72
abstract_inverted_index.E,	73
abstract_inverted_index.F,	91
abstract_inverted_index.G,	136
abstract_inverted_index.H,	170
abstract_inverted_index.I,	196
abstract_inverted_index.J,	261
abstract_inverted_index.SD	126
abstract_inverted_index.an	34
abstract_inverted_index.as	123, 227
abstract_inverted_index.at	177, 264
abstract_inverted_index.in	20, 43, 88, 95, 144, 204, 272
abstract_inverted_index.is	155
abstract_inverted_index.of	4, 36, 52, 77, 102, 106, 111, 114, 127, 138, 199, 208, 221, 246, 267
abstract_inverted_index.on	217
abstract_inverted_index.or	15
abstract_inverted_index.to	58, 118, 252
abstract_inverted_index.±	125, 229
abstract_inverted_index.(to	130
abstract_inverted_index.24h	19
abstract_inverted_index.MKI	112, 115
abstract_inverted_index.SD.	230
abstract_inverted_index.YAP	5
abstract_inverted_index.and	25, 67, 109, 151, 256
abstract_inverted_index.are	29, 33, 70, 121, 225, 236
abstract_inverted_index.day	131, 218
abstract_inverted_index.for	18
abstract_inverted_index.n=5	231
abstract_inverted_index.per	182, 232
abstract_inverted_index.set	48
abstract_inverted_index.the	222, 244, 265, 268
abstract_inverted_index.was	116, 160, 186, 215
abstract_inverted_index.6E).	38
abstract_inverted_index.Ctrl	152, 253
abstract_inverted_index.Data	120, 224
abstract_inverted_index.Fig.	37
abstract_inverted_index.Gene	47
abstract_inverted_index.YAPC	21, 44, 97, 147, 201
abstract_inverted_index.blot	2, 41, 75
abstract_inverted_index.data	54
abstract_inverted_index.from	55, 210
abstract_inverted_index.gene	150
abstract_inverted_index.mRNA	140
abstract_inverted_index.mean	124, 228
abstract_inverted_index.n=10	181
abstract_inverted_index.n=3.	157
abstract_inverted_index.over	249
abstract_inverted_index.qPCR	137
abstract_inverted_index.time	179
abstract_inverted_index.with	167, 193, 258
abstract_inverted_index.%GFP+	129
abstract_inverted_index.(BH).	260
abstract_inverted_index.(Data	31
abstract_inverted_index.(Dox)	9
abstract_inverted_index.(NES)	66
abstract_inverted_index.(Nuc)	24
abstract_inverted_index.GFP).	119
abstract_inverted_index.MARK2	139
abstract_inverted_index.MKIWT	14, 56, 209
abstract_inverted_index.Tumor	171, 262
abstract_inverted_index.after	99, 133
abstract_inverted_index.cells	98
abstract_inverted_index.empty	11
abstract_inverted_index.genes	108
abstract_inverted_index.group	254
abstract_inverted_index.image	263
abstract_inverted_index.mice.	206
abstract_inverted_index.mixed	240
abstract_inverted_index.model	242
abstract_inverted_index.score	65
abstract_inverted_index.sgRNA	103
abstract_inverted_index.shown	32, 122, 226, 271
abstract_inverted_index.time)	250
abstract_inverted_index.using	162, 174, 188, 238
abstract_inverted_index.value	69, 159, 185
abstract_inverted_index.(-Dox)	255
abstract_inverted_index.(Cyto)	27
abstract_inverted_index.(GSEA)	51
abstract_inverted_index.CRISPR	142
abstract_inverted_index.Growth	197
abstract_inverted_index.MKIMUT	16, 59
abstract_inverted_index.analog	84
abstract_inverted_index.assays	94
abstract_inverted_index.cells.	22, 45, 62, 90, 148, 223
abstract_inverted_index.group.	183, 233
abstract_inverted_index.groups	248
abstract_inverted_index.linked	117
abstract_inverted_index.mutant	86
abstract_inverted_index.n=3-9.	135
abstract_inverted_index.shown.	71, 156
abstract_inverted_index.t-test	166, 192
abstract_inverted_index.values	235
abstract_inverted_index.vector	12
abstract_inverted_index.volume	172
abstract_inverted_index.MARK2,3	78
abstract_inverted_index.Nuclear	23
abstract_inverted_index.RNA-seq	53
abstract_inverted_index.Western	1, 40, 74
abstract_inverted_index.effects	241
abstract_inverted_index.fitness	93
abstract_inverted_index.imaging	176
abstract_inverted_index.induced	10, 216
abstract_inverted_index.points.	180
abstract_inverted_index.HEK-293T	89
abstract_inverted_index.analysis	3, 42, 50, 76
abstract_inverted_index.compared	57, 251
abstract_inverted_index.control,	13
abstract_inverted_index.dCas9VPR	145
abstract_inverted_index.kinetics	198
abstract_inverted_index.specific	79
abstract_inverted_index.MDA-MB231	61
abstract_inverted_index.NIS-SPECT	175
abstract_inverted_index.Welch’s	168, 194
abstract_inverted_index.construct	214
abstract_inverted_index.corrected	257
abstract_inverted_index.cytosolic	26
abstract_inverted_index.end-point	266
abstract_inverted_index.extension	35
abstract_inverted_index.following	7, 82, 141
abstract_inverted_index.implanted	203
abstract_inverted_index.indicated	107, 178
abstract_inverted_index.promoters	105
abstract_inverted_index.sensitive	85
abstract_inverted_index.targeting	104
abstract_inverted_index.xenograft	269
abstract_inverted_index.Expression	207
abstract_inverted_index.Normalized	63
abstract_inverted_index.activation	143
abstract_inverted_index.calculated	161, 187, 237
abstract_inverted_index.enrichment	49, 64
abstract_inverted_index.expressing	60, 146
abstract_inverted_index.expression	17, 101, 110, 154
abstract_inverted_index.indicated.	30
abstract_inverted_index.lentiviral	100, 213
abstract_inverted_index.normalized	128, 153
abstract_inverted_index.parametric	165, 191
abstract_inverted_index.substrates	80
abstract_inverted_index.two-tailed	164, 190
abstract_inverted_index.xenografts	202
abstract_inverted_index.<p>A,	0
abstract_inverted_index.(expression	113
abstract_inverted_index.MKI/MARK2,3	83
abstract_inverted_index.correction.	169, 195
abstract_inverted_index.doxycycline	8, 211
abstract_inverted_index.experiments	270
abstract_inverted_index.infection).	134
abstract_inverted_index.interaction	245
abstract_inverted_index.(considering	243
abstract_inverted_index.Housekeeping	149
abstract_inverted_index.I.</p>	273
abstract_inverted_index.experimental	247
abstract_inverted_index.localization	6
abstract_inverted_index.subcutaneous	200
abstract_inverted_index.fractionation	28
abstract_inverted_index.post-injection	220
abstract_inverted_index.quantification	173
abstract_inverted_index.(Dox)-inducible	212
abstract_inverted_index.Bonferroni-Holm	259
abstract_inverted_index.immunodeficient	205
abstract_inverted_index.phosphorylation	81
abstract_inverted_index.Competition-based	92
abstract_inverted_index.co-overexpression	87
abstract_inverted_index.dCas9VPR-expressing	96
cited_by_percentile_year
countries_distinct_count	0
institutions_distinct_count	19
sustainable_development_goals[0].id	https://metadata.un.org/sdg/3
sustainable_development_goals[0].score	0.4300000071525574
sustainable_development_goals[0].display_name	Good health and well-being
citation_normalized_percentile.value	0.28406966
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False